Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births

BACKGROUND: In 2005, the FDA cautioned that exposure to paroxetine, a selective serotonin reuptake inhibitor (SSRI), during the first trimester of pregnancy may increase the risk of cardiac malformations. Since then, the association between maternal use of SSRIs during pregnancy and congenital malfo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Med
Main Authors: Gao, Shan-Yan, Wu, Qi-Jun, Sun, Ce, Zhang, Tie-Ning, Shen, Zi-Qi, Liu, Cai-Xia, Gong, Ting-Ting, Xu, Xin, Ji, Chao, Huang, Dong-Hui, Chang, Qing, Zhao, Yu-Hong
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231277/
https://ncbi.nlm.nih.gov/pubmed/30415641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-018-1193-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker